Preoperative depression as a neuroimmune-cholinergic vulnerability state for postoperative cognitive dysfunction after gastrointestinal cancer surgery
World Journal of Gastrointestinal Surgery · 2026-11-27 · 18 (11)
DOI: 10.4240/wjgs.119120 ↗Abstract
Postoperative cognitive dysfunction, a legacy term broadly corresponding to the postoperative spectrum within the contemporary perioperative neurocognitive disorders framework, is a frequent and clinically consequential complication after gastrointestinal (GI) cancer surgery in older adults. Preoperative depression is increasingly recognized as a high-impact risk factor, yet its biological links to perioperative brain vulnerability remain underappreciated. Li et al recently published a study in World Journal of Gastrointestinal Surgery , examining postoperative cognitive outcomes in depressed older adults undergoing GI tumor surgery, with particular emphasis on inflammatory and cholinergic mechanisms. Li et al report a substantial burden of postoperative cognitive impairment and identify a dual-pathway pattern in which postoperative inflammatory signaling - indexed by interleukin-6 as a representative perioperative cytokine - and reduced peripheral cholinesterase activity are associated with excess cognitive risk in patients with preoperative depression. Conceptually, these findings support reframing depression as a neuroimmune-cholinergic vulnerability state that may amplify perioperative susceptibility through interacting inflammatory and neuromodulatory processes. While mechanistic in nature and hypothesis-generating, this framework suggests that preoperative depression screening may inform future risk stratification strategies and motivate investigation of inflammation-aware, cholinergic-sensitive, and psychosocially integrated perioperative care approaches. A neuropsychiatric-immune-cholinergic perspective provides a coherent conceptual framework for understanding heterogeneity in postoperative neurocognitive outcomes after GI cancer surgery and highlights preoperative depression as a biologically relevant vulnerability state warranting further prospective investigation.
EUVIMED